Literature DB >> 26568798

Repeated spurious elevation of serum prostate-specific antigen values solved by chemiluminescence analysis: A possible interference by heterophilic antibodies.

Arturo Domínguez1, Miquel Bayó2, Jesús Muñoz-Rodríguez1, Jose Antonio Bellido1, Jose María Abascal-Junquera1, Naim Hannaoui1, Josep Maria Banús1.   

Abstract

Heterophilic antibodies are human immunoglobulins directed against various animal antigens. They can produce false-positive results in the analysis of different tumor markers, including prostate-specific antigen. This interference can lead to misdiagnosis, unnecessary tests, and overtreatment in some cases. We present herein the case of a 52-year-old man with repeated spurious elevation of prostate-specific antigen, reaching levels of 108.7 ng/mL, that were suspected to be caused by heterophilic antibodies. The interference was solved by changing the analysis technique. Real values of prostate-specific antigen were less than 1 ng/mL.

Entities:  

Keywords:  Analysis; Diagnosis; Heterophile antibodies; Immunoassay; Prostate-specific antigen

Mesh:

Substances:

Year:  2015        PMID: 26568798      PMCID: PMC4643176          DOI: 10.4111/kju.2015.56.11.785

Source DB:  PubMed          Journal:  Korean J Urol        ISSN: 2005-6737


  10 in total

1.  Falsely increased prostate-specific antigen concentration attributed to heterophilic antibodies.

Authors:  Tomás Camacho; Josefina Mora; Ana Segura; Javier Guitián; Fernando Lema; Jesús Bandín; José Rodríguez-Espinosa
Journal:  Ann Clin Biochem       Date:  2002-03       Impact factor: 2.057

Review 2.  Towards a better understanding of heterophile (and the like) antibody interference with modern immunoassays.

Authors:  Stanley S Levinson; James J Miller
Journal:  Clin Chim Acta       Date:  2002-11       Impact factor: 3.786

Review 3.  Endogenous interference in immunoassays in clinical chemistry. A review.

Authors:  T H Weber; K I Käpyaho; P Tanner
Journal:  Scand J Clin Lab Invest Suppl       Date:  1990

4.  False elevations in prostate-specific antigen levels affecting patient management.

Authors:  Shivaani Kummar; Nelofar Q Shafi
Journal:  Clin Adv Hematol Oncol       Date:  2004-09

5.  Artificial prostate-specific antigen persistence after radical prostatectomy.

Authors:  Cédric Poyet; Danielle Hof; Tullio Sulser; Michael Müntener
Journal:  J Clin Oncol       Date:  2011-12-27       Impact factor: 44.544

6.  Interference by human anti-mouse antibody in two-site immunoassays.

Authors:  L J Kricka; D Schmerfeld-Pruss; M Senior; D B Goodman; P Kaladas
Journal:  Clin Chem       Date:  1990-06       Impact factor: 8.327

7.  Serum heterophile antibodies interfere with prostate specific antigen test and result in over treatment in a patient with prostate cancer.

Authors:  B R Morgan; T H Tarter
Journal:  J Urol       Date:  2001-12       Impact factor: 7.450

8.  Spurious prostate-specific antigen (PSA) recurrence after radical prostatectomy: interference by human antimouse heterophile antibodies.

Authors:  Sangtae Park; Frank H Wians; Jeffrey A Cadeddu
Journal:  Int J Urol       Date:  2007-03       Impact factor: 3.369

9.  New onset of heterophilic antibody interference in prostate-specific antigen measurement occurring during the period of post-prostatectomy prostate-specific antigen monitoring.

Authors:  B E Fritz; R J Hauke; D F Stickle
Journal:  Ann Clin Biochem       Date:  2009-03-05       Impact factor: 2.057

10.  Inappropriate treatment of prostate cancer caused by heterophilic antibody interference.

Authors:  Nicolas Henry; Phillipe Sebe; Olivier Cussenot
Journal:  Nat Clin Pract Urol       Date:  2009-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.